Avid Bioservices Incの将来のP / E

Avid Bioservices Incの将来のP / Eは何ですか。

Avid Bioservices Incの将来のP / Eは73.94です。

将来のP / Eの定義は何ですか。



未来比率P / E (株価収益率)は、企業の株価と今後12ヶ月間の1株当たり利益見込額との比率です。

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

NASDAQのセクタHealth Careにおける将来のP / Eの企業と比べるAvid Bioservices Inc

Avid Bioservices Incは何をしますか。

avid bioservices, a subsidiary of peregrine pharmaceuticals, inc. (nasdaq: pphm), is a unique contract manufacturing organization ("cmo") partner dedicated to the development and production of monoclonal antibodies, recombinant proteins and enzymes produced in mammalian cell culture. our extensive experience at all stages of development enables us to provide comprehensive development, manufacturing and support services to navigate a biologic from concept to commercialization.

Avid Bioservices Incと類似の将来のp / e